Research Paper Volume 12, Issue 6 pp 4866—4878

MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer

Figure 2. ROC analysis demonstrating that serum miR-519d levels can distinguish NSCLC patients from healthy controls.